Exclusive: Greenwich LifeSciences CEO Calls Stock's Meteoritic Rise 'Very Emotional'
Greenwich LifeSciences, Inc. (NASDAQ: GLSI) is a biopharmaceutical company that is developing GP2, an immunotherapy to prevent breast cancer recurrences in certain patients.
